Leonteq Securities’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$171 Hold
26
– – ﹤0.01% 1259
2026
Q2
$136 Hold
26
– – ﹤0.01% 1246
2026
Q1
$97 Hold
26
– – ﹤0.01% 1257
2025
Q4
$213 Hold
26
– – ﹤0.01% 1394
2025
Q3
$191 Hold
26
– – ﹤0.01% 1291
2025
Q2
$211 Hold
26
– – ﹤0.01% 1235
2025
Q1
$183 Hold
26
– – ﹤0.01% 1199
2024
Q4
$193 Hold
26
– – ﹤0.01% 1221
2024
Q3
$128 Hold
26
– – ﹤0.01% 1174
2024
Q2
$133 Hold
26
– – ﹤0.01% 1173
2024
Q1
$138 Hold
26
– – ﹤0.01% 1182
2023
Q4
$161 Hold
26
– – ﹤0.01% 1171
2023
Q3
$196 Hold
26
– – ﹤0.01% 1179
2023
Q2
$251 Hold
26
– – ﹤0.01% 1198
2023
Q1
$98 Hold
26
– – ﹤0.01% 1180
2022
Q4
$168 Hold
26
– – ﹤0.01% 1253
2022
Q3
$231 Hold
26
– – ﹤0.01% 1242
2022
Q2
$259 Buy
+26
New +$257 ﹤0.01% 1245

Other funds holding LFCR

Leonteq Securities's LFCR Position: Q3 2026 in Review

Leonteq Securities held its Lifecore Biomedical (LFCR) position steady in Q3 2026 at 26 shares worth $171. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Leonteq Securities first reported a position in LFCR in Q2 2022 and has held it in 18 quarters since. The position peaked at $259 in Q2 2022. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • Leonteq Securities held 26 shares of Lifecore Biomedical worth $171 as of Q3 2026.
  • Leonteq Securities left its Lifecore Biomedical share count unchanged in Q3 2026.
  • Lifecore Biomedical made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1259 holding.
  • Leonteq Securities first reported a position in Lifecore Biomedical in Q2 2022 and has held it in 18 quarters since.
  • Leonteq Securities's Lifecore Biomedical position peaked at $259 in Q2 2022.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.